Community-acquired Haemophilus influenzae pneumonia - New insights from the CAPNETZ study

Journal of Infection

Volumn 72, Issue 5, 2016, Pages 554-563

  Forstner, Christina ^a,b   Rohde, Gernot ^c,i,j   Rupp, Jan ^d,j   Schuette, Hartwig ^e,j   Ott, Sebastian R ^f   Hagel, Stefan ^a   Harrison, Nicole ^b   Thalhammer, Florian ^b   von Baum, Heike ^g   Suttorp, Norbert ^e,j   Welte, Tobias ^h,i,j   Pletz, Mathias W ^a,j   Kruger S ^k   Frechen, D ^k   Knuppel W ^l   Armari, I ^l   Stolz, D ^m   Suttorp, N ^e   Schutte H ^e   Creutz, P ^e   Bauer, T ⁿ   Hecht, J ⁿ   Pankow, W ^o   Lies, A ^o   Thiemig, D ^o   Hauptmeier, B ^p   Wehde, D ^p   Suermann, M ^p   Ewig, S ^q   Prediger, M ^r   Zernia, G ^r   Rademacher, J ^h   Barten, G ^s   Abrahamczik, M ^s   Naim, J ^s   Kroner W ^s   Illig, T ^t   Klopp, N ^t   Kroegel, C ^a   Bals, R ^u   Dalhoff, K ^v   Schutz S ^v   Horster R ^v   Rohde, G ^c   Petermann, W ^w   Buschmann, H ^w   Kroning R ^w   Aydin, Y ^w   Schaberg, T ^x   Hering, I ^x   Marre, R ^y   Schumann, C ^y   von Baum, H ^g   Illmann, T ^z   Wallner, M ^z   Burghuber, O ^aa   Rainer, G ^aa   more..

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF LÜBECK   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITY OF BERN   (Switzerland)

^g UNIVERSITY HOSPITAL ULM   (Germany)

^h HANNOVER MEDICAL SCHOOL   (Germany)

ⁱ German Center for Lung Research   (Germany)

^j CAPNETZ STIFTUNG   (Germany)

^k UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^l Clinic for Internal Medicine Hospital Bad Arolsen   (Germany)

^m Clinic for Pneumology Uni Spital   (Germany)

ⁿ HELIOS KLINIKUM EMIL VON BEHRING   (Germany)

^o Clinic for Internal Medicine e Pneumology and Infektiology e Vivantes Clinical Center   (Germany)

^p RUHR UNIVERSITY BOCHUM   (Germany)

^q Augusta Kranken Anstalt   (Germany)

^r Carl   (Germany)

^s Main Office   (Germany)

^t Hannover Unified Biobank   (Germany)

^u SAARLAND UNIVERSITY   (Germany)

^v UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^w Brotherhospital St Josef   (Germany)

^x Deaconess Hospital Rotenburg   (Germany)

^y UNIVERSITY OF ULM   (Germany)

^z 2mt Software GmbH   (Germany)

^aa Otto Wagner Spital Wien   (Germany)

more..

Author keywords

Beta lactams; CURB 65 score; Fluoroquinolones; Haemophilus influenzae; Macrolides; Respiratory tract infection

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; KETOLIDE; LINEZOLID; MACROLIDE; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TELITHROMYCIN; TETRACYCLINE; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; CHRONIC LIVER DISEASE; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; COMMUNITY ACQUIRED PNEUMONIA; DRUG RESPONSE; FEMALE; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY (TOPIC); NONHUMAN; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; VACCINATION; ADOLESCENT; AGED; CLINICAL TRIAL; COMMUNITY-ACQUIRED INFECTIONS; GERMANY; HAEMOPHILUS INFECTIONS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PNEUMONIA, BACTERIAL; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; GERMANY; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84960154629     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2016.02.010     Document Type: Article

References (29)

1. Musher D.M., Kubitschek K.R., Crennan J., Baughn R.E. Pneumonia and acute febrile tracheobronchitis due to Haemophilus influenzae. Ann Intern Med 1983, 99:444-450.
2. Torres A., Blasi E., Peetermans W.E., Viegi G., Welte T. The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review. Eur J Clin Microbiol Infect Dis 2014, 33:1065-1079. 10.1007/s10096-014-2067-1.
3. Kofteridis D., Samonis G., Mantadakis E., Maraki S., Chrysofakis G., Alegakis D., et al. Lower respiratory tract infections caused by Haemophilus influenzae: clinical features and predictors of outcome. Med Sci Monit 2009, 15:CR135-CR139.
4. Garcia-Vidal C., Carratala J., Fernandez-Sabe N., Dorca J., Verdaguer R., Manresa F., et al. Aetiology of, and risk factors for, recurrent community-acquired pneumonia. Clin Microbiol Infect 2009, 15:1033-1038. 10.1111/j.1469-0691.2009.02918.x.
5. De Schutter I., De Wachter E., Crokaert F., Verhaegen J., Soetens O., Piérard D., et al. Microbiology of bronchoalveolar lavage fluid in children with acute nonresponding or recurrent community-acquired pneumonia: identification of nontypeable Haemophilus influenzae as a major pathogen. Clin Infect Dis 2011, 52:1437-1444. 10.1093/cid/cir235.
6. Wallace R.J., Musher D.M., Septimus E.J., McGowan J.E., Quinones F.J., Wiss K., et al. Haemophilus influenzae infections in adults: characterization of strains by serotypes, biotypes, and beta-lactamase production. J Infect Dis 1981, 144:101-106.
7. Schuchat A., Messonnier N.R. From pandemic suspect to the postvaccine era: the Haemophilus influenzae story. Clin Infect Dis 2007, 44:817-819.
8. Peric M., Bozdogan B., Jacobs M.R., Appelbaum P.C. Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates. Antimicrob Agents Chemother 2003, 47:1017-1022.
9. Bogdanovich T., Bozdogan B., Appelbaum P.C. Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae. Antimicrob Agents Chemother 2006, 50:893-898.
10. Tristram S., Jacobs M.R., Appelbaum P.C. Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev 2007, 20:368-389.
11. Jacobs M.R., Johnson C.E. Macrolide resistance: an increasing concern for treatment failure in children. Pediatr Infect Dis J 2003, 22(Suppl. 8):S131-S138.
12. Howie V.M., Ploussard J.H. Efficacy of fixed combination antibiotics versus separate components in otitis media. Effectiveness of erythromycin estrolate, triple sulfonamide, ampicillin, erythromycin estolate- triple sulfonamide, and placebo in 280 patients with acute otitis media under two and one-half years of age. Clin Pediatr 1972, 11:205-214.
13. Van Eldere J., Slack M.P., Ladhani S., Cripps A.W. Non-typeable Haemophilus influenzae, an under-recognised pathogen. Lancet Infect Dis 2014, 14(12):1281-1292. 10.1016/S1473-3099(14)70734-0.
14. Woodhead M., Blasi F., Ewig S., Garau J., Huchon G., Ieven M., et al. Guidelines for the management of adult lower respiratory tract infections - full version. Clin Microbiol Infect 2011, 17(Suppl. 6):E1-E59. 10.1111/j.1469-0691.2011.03672.x.
15. Mandell L.A., Wunderink R.G., Anzueto A., Bartlett J.G., Campbell G.D., Dean N.C., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44(Suppl. 2):S27-S72.
16. Welte T., Suttorp N., Marre R. CAPNETZ-community-acquired pneumonia competence network. Infection 2004, 32:234-238.
17. Lim W.S., van der Eerden M.M., Laing R., Boersma W.G., Karalus N., Town G.I., et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003, 58:377-382.
18. File T.M., Wilcox M.H., Stein G.E. Summary of ceftaroline fosamil clinical trial studies and clinical safety. Clin Infect Dis 2012, 55(Suppl. 3):S173-S180. 10.1093/cid/cis559.
19. Bartlett JG, Ryan KJ, Smith TF, Wilson WR. Cumitech 7A, Laboratory diagnosis of lower respiratory tract infections. Coordinating ed., J.A. Washington II. 1987. American Society for Microbiology, Washington, D.C.
20. Pletz M.W., von Baum H., van der Linden M., Rohde G., Schütte H., Suttorp N., et al. The burden of pneumococcal pneumonia - experience of the German competence network CAPNETZ. Pneumologie 2012, 66:470-475.
21. von Baum H., Welte T., Marre R., Suttorp N., Lück C., Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ). BMC Infect Dis 2009, 9:62. 10.1186/1471-2334-9-62.
22. The European Committee on Antimicrobial Susceptibility Testing MIC determination of nonfastidious and fastidious organisms - broth microdilution methodology to ISO and EUCAST. Version 2.0 May 2012.
23. Food and Drug Administration, Division of Anti-Infective Products. Office of Antimicrobial Products. Briefing document. Endpoints and clinical trial issues in community-acquired bacterial pneumonia. Food and Drug Administration, Division of Anti-Infective Products, Office of Antimicrobial Products, Washington, DC: [last updated 03.11.11. last accessed 20.06.15.]. http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/drugs/anti-infectivedrugsadvisorycommittee/ucm275823.pdf.
24. Cohen J., Cohen P., West S.G. Applied multiple regression/correlation analysis for the behavioral sciences 2002, Lawrence Erlbaum, Mahwah, NJ. 3rd ed.
25. Gomez-Junyent J., Garcia-Vidal C., Viasus D., Millat-Martínez P., Simonetti A., Santos M.S., et al. Clinical features, etiology and outcomes of community-acquired pneumonia in patients with chronic obstructive pulmonary disease. PLoS One 2014, 9:e105854. 10.1371/journal.pone.0105854.
26. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 2002, 34:482-492.
27. Welte T. Managing CAP patients at risk of clinical failure. Respir Med 2015, 109:157-169. 10.1016/j.rmed.2014.10.018.
28. Frickmann H., Podbielski A., Essig A., Schwarz N.G., Zautner A.E. Difficulties in species identification within the genus Haemophilus - a pilot study addressing a significant problem for routine diagnostics. Eur J Microbiol Immunol 2014, 4:99-105.
29. Höffken G., Lorenz J., Kern W., Welte T., Bauer T., Dalhoff K., et al. Epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults. Guidelines of the Paul-Ehrlich-Society for Chemotherapy, the German Respiratory Society, the German Society for Infectiology and Competence Network CAPNETZ Germany. Pneumologie 2009, 63:e1-e68. 10.1055/s-0029-1215037.